Cited by 1,001Lipoproteins and Cardiovascular HealthCardiac and Coronary Surgery TechniquesCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

Open access

Buchwald, Henry, Varco, Richard L., Matts, John P., Long, John M., Fitch, Laurie L., Campbell, Gilbert S., Pearce, Malcolm B., Yellin, Albert E., Edmiston, W. Allan, Smink, Robert D., Sawin, Henry S., Campos, Christian T., Hansen, Betty J., Tuna, Naip, Karnegis, James N., Sanmarco, Miguel E., Amplatz, Kurt, Castaneda-Zuniga, Wilfredo R., Hunter, David W., Bissett, Joseph K., Weber, Frederic J., Stevenson, James W., Leon, Arthur S., Chalmers, Thomas C.·1990·New England Journal of Medicine

DOI 10.1056/nejm199010043231404

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND AND METHODS: The Program on the Surgical Control of the Hyperlipidemias (POSCH), a randomized clinical trial, was designed to test whether cholesterol lowering induced by the partial ileal bypass operation would favorably affect overall mortality or mortality due to coronary heart disease. The study population consisted of 838 patients (417 in the control group and 421 in the surgery group), both men (90.7 percent) and women, with an average age of 51 years, who had survived a first myocardial infarction. The mean follow-up period was 9.7 years. RESULTS: When compared with the control group at five years, the surgery group had a total plasma cholesterol level 23.3 percent lower (4.71 +/- 0.91 vs. 6.14 +/- 0.89 mmol per liter [mean +/- SD]; P less than 0.0001), a low-density lipoprotein cholesterol level 37.7 percent lower (2.68 +/- 0.78 vs. 4.30 +/- 0.89 mmol per liter; P less than 0.0001), and a high-density lipoprotein cholesterol level 4.3 percent higher (1.08 +/- 0.26 vs. 1.04 +/- 0.25 mmol per liter; P = 0.02). Overall mortality and mortality due to coronary heart disease were reduced, but not significantly so (deaths overall [control vs. surgery], 62 vs. 49, P = 0.164; deaths due to coronary disease, 44 vs. 32, P = 0.113). The overall mortality in the surgery subgroup with an ejection fraction greater than or equal to 50 percent was 36 percent lower (control vs. surgery, 39 vs. 24; P = 0.021). The value for two end points combined--death due to coronary heart disease and confirmed nonfatal myocardial infarction--was 35 percent lower in the surgery group (125 vs. 82 events; P less than 0.001). During follow-up, 137 control-group and 52 surgery-group patients underwent coronary-artery bypass grafting (P less than 0.0001). A comparison of base-line coronary arteriograms with those obtained at 3, 5, 7, and 10 years consistently showed less disease progression in the surgery group (P less than 0.001). The most common side effect of partial ileal bypass was diarrhea; others included occasional kidney stones, gallstones, and intestinal obstruction. CONCLUSIONS: Partial ileal bypass produces sustained improvement in the blood lipid patterns of patients who have had a myocardial infarction and reduces their subsequent morbidity due to coronary heart disease. The role of this procedure in the management of hypercholesterolemia remains to be determined. These results provide strong evidence supporting the beneficial effects of lipid modification in the reduction of atherosclerosis progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199010043231404

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Practical Nonparametric Statistics
Groggel, D. J., & Conover, W. J. (2000) · Technometrics · doi:10.2307/1271101 · Cited by 11,076
Immunochemical quantitation of antigens by single radial immunodiffusion
Mancini, G., Carbonara, A. O., & Heremans, J. F. (1965) · Immunochemistry · doi:10.1016/0019-2791(65)90004-2 · Cited by 9,091
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in Incidence of Coronary Heart Disease
(1984) · JAMA · doi:10.1001/jama.1984.03340270029025 · Cited by 2,747
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160

Show all 58 references

Research works printed but not linked: 29

10.1001/jama.256.20.2823 · DOI · Paper page
Leren, 1966, Acta Med Scand Suppl, 466, 1
1968, Lancet, 2, 693
Frantz, 1975, Circulation, 52, II-4
10.1001/jama.231.4.360 · DOI
10.1001/jama.251.3.351 · DOI · Paper page
10.1001/jama.257.23.3233 · DOI
Buchwald H. Intestinal bypass for hypercholesterolemia. In: Nyhus LM, Baker RJ, eds. Mastery of surgery. Vol. 3. Boston: Little, Brown, 1984:901–7.
Buchwald H, Campos CT. Partial ileal bypass for control of hyperlipidemia and atherosclerosis. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest. 5th ed. Philadelphia: W.B. Saunders, 1990:1799–819.
Schouten, 1986, Artery, 13, 240
1959, Stat Bull Metrop Life Insur Co, 40, 1
Bruce, 1971, Ann Clin Res, 3, 323
National Heart and Lung Institute, Lipid Research Clinics Program. Manual of laboratory operations. Vol. 1. Bethesda, Md.: National Institutes of Health, 1974. (DHEW publication no. (NIH) 75–628.)
1970, Bull World Health Organ, 43, 891
Mantel, 1966, Cancer Chemother Rep, 50, 163
Matts, Controlled Clin Trials
Campos, 1987, Surgery, 102, 424
Campos, 1988, Curr Surg, 45, 380
Campos, 1988, Surg Forum, 39, 193
Addison, 1851, Guys Hosp Rep, 2, 267
Ignatovski, 1908, Izviest Imp Voyenno-med Akad S Petersb, 16, 154
Anitschkow, 1913, Centralbl Allg Pathol Pathol Anat, 24, 1
Wacker, 1913, Münchener Med Wochenschr, 60, 2097
European Coronary Surgery Study Group, 1982, Lancet, 2, 1173
Buchwald, 1965, Surgery, 58, 22
Scott, 1967, Surg Gynecol Obstet, 125, 3
Buchwald, 1963, Circulation, 28, II-649
Moore, 1969, Surgery, 65, 98
Buchwald, Ann Surg

Sorted by citations

Items 201–300 of 1,000

Modern Management of Acute Myocardial Infarction
Yang, E. H., Brilakis, E. S., Reeder, G. S., & Gersh, B. J. (2006) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2006.08.004 · Cited by 76
Overexpression of Cholesterol 7α-Hydroxylase (CYP7A) in Mice Lacking the Low Density Lipoprotein (LDL) Receptor Gene
Spady, D. K., Cuthbert, J. A., Willard, M. N., & Meidell, R. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.126 · Cited by 75
Vertical Banded Gastroplasty Versus Standard or Distal Roux-en-Y Gastric Bypass Based on Specific Selection Criteria in the Morbidly Obese: Preliminary Results
Kalfarentzos, F. E., Dimakopoulos, A., Kehagias, I., Loukidi, A., & Mead, N. (1999) · Obesity Surgery · doi:10.1381/096089299765552701 · Cited by 75
Hypocholesterolemia and Affective Disorders
Glueck, C. J., Tieger, M., Kunkel, R., Hamer, T., Tracy, T., & Speirs, J. (1994) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199430840-00002 · Cited by 75
The Estrogen Replacement and Atherosclerosis (ERA) Study
Herrington, D. M., Reboussin, D. M., Klein, K. P., Sharp, P. C., Shumaker, S. A., Snyder, T. E., & Geisinger, K. R. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00054-4 · Cited by 74
Pleiotropic Effects of Statins: Evidence Against Benefits Beyond LDL-Cholesterol Lowering
Pedersen, T. R. (2010) · American Journal Cardiovascular Drugs · doi:10.2165/1158822-s0-000000000-00000 · Cited by 74
Triglycerides are more important in atherosclerosis than epidemiology has suggested
Durrington, P. N. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00219-6 · Cited by 72
Overall Mortality, Incremental Life Expectancy, and Cause of Death at 25 Years in the Program on the Surgical Control of the Hyperlipidemias
Buchwald, H., Rudser, K. D., Williams, S. E., Michalek, V. N., Vagasky, J., & Connett, J. E. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181deb4d0 · Cited by 73
Self-citation
Familial Hypercholesterolemia
Klose, G., Laufs, U., März, W., & Windler, E. E. T. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0523 · Cited by 73
Why are low-density lipoproteins atherogenic?
Young, S. G., & Parthasarathy, S. (1994) · PubMed Central · Cited by 72
Lipid-Lowering Drugs in the Management of Hyperlipidaemia
Bhatnagar, D. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00018-7 · Cited by 74
Cholesterol, cholesterol lowering, and endothelial function
VOGEL, R., Corretti, M. C., & Gellman, J. (1998) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(98)80008-x · Cited by 71
Preventing and arresting coronary atherosclerosis.
Roberts, W. C. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90369-0 · Cited by 76
I Diretriz Brasileira de Hipercolesterolemia Familiar (HF)
Santos, R., Gagliardi, A., Xavier, H. T., Filho, A. C., Araújo, D., Cesena, F., Alves, R., Pereira, A., Lotemberg, A., Chacra, A., et al. (2012) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20120202 · Cited by 70
Lipids and Atherosclerosis: Lessons Learned from Randomized Controlled Trials of Lipid Lowering and Other Relevant Studies
Kreisberg, R. A., & Oberman, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8057 · Cited by 70
Weight Loss Following Vertical Banded Gastroplasty: Intermediate Results of a Prospective Study
Kalfarentzos, F. E., Kechagias, I., Soulikia, K., Loukidi, A., & Mead, N. (2001) · Obesity Surgery · doi:10.1381/096089201321336566 · Cited by 70
The effects of fibrates on lipoprotein and hemostatic coronary risk factors.
Schonfeld, G. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90090-6 · Cited by 78
Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH)
Buchwald, H., Campos, C. T., Boen, J. R., Nguyen, P. A., & Williams, S. E. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)80006-3 · Cited by 69
Self-citation
Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome
Denke, M. A., Pearson, T. A., McBride, P. E., Gazzara, R. A., Brady, W. E., & Tershakovec, A. M. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.020 · Cited by 68
Effects of Cholesterol Lowering on the Progression of Coronary Atherosclerosis in Women
Waters, D. D., Higginson, L., Gladstone, P. J., Boccuzzi, S. J., Cook, T. J., & Lespérance, J. (1995) · Circulation · doi:10.1161/01.cir.92.9.2404 · Cited by 68
Role of lipid and lipoprotein profiles in risk assessment and therapy
Ballantyne, C. M., & Hoogeveen, R. C. (2003) · American Heart Journal · doi:10.1016/s0002-8703(02)94701-0 · Cited by 68
Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94
Root, C., Smith, C. D., Sundseth, S. S., Pink, H. M., Wilson, J. G., & Lewis, M. C. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200121-jlr200 · Cited by 68
Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I.
Rudling, M. J., Olivecrona, H., Eggertsen, G., & Angelin, B. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118415 · Cited by 68
Inhibition of Ileal Na+/Bile Acid Cotransporter by S-8921 Reduces Serum Cholesterol and Prevents Atherosclerosis in Rabbits
Higaki, J., Hara, S., Takasu, N., Tonda, K., Miyata, K., Shike, T., Nagata, K., & Mizui, T. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.8.1304 · Cited by 68
Lipid-lowering effect of a dietary chromium (III)—Nicotinic acid complex in male athletes
Lefavi, R. G., Dennis Wilson, G., Keith, R. E., Anderson, R. A., Blessing, D. L., Hames, C. G., & McMillan, J. L. (1993) · Nutrition Research · doi:10.1016/s0271-5317(05)80421-x · Cited by 67
Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art
Crouse, J. R. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600012-jlr200 · Cited by 66
Rationale for treatment
Gotto, A. M. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90054-2 · Cited by 66
Gastric bypass reduces biochemical cardiac risk factors
Williams, D. B., Hagedorn, J. C., Lawson, E. H., Galanko, J. A., Safadi, B. Y., Curet, M. J., & Morton, J. M. (2006) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2006.10.003 · Cited by 66
New lipid-lowering drugs: an update
Wierzbicki, A. S., Hardman, T. C., & Viljoen, A. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02867.x · Cited by 65
Beyond Lipid Lowering: What Have We Learned About the Benefits of Statins from the Acute Coronary Syndromes Trials?
Ray, K. K., Cannon, C. P., & Ganz, P. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.09.016 · Cited by 64
Systemic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease
Criqui, M. H. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01881-1 · Cited by 65
Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarction
(1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90438-i · Cited by 65
Effects of cardiac rehabilitation and exercise training on low-density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease
Lavie, C. J., & Milani, R. V. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90546-0 · Cited by 65
Cholesterol Absorption From the Intestine Is a Major Determinant of Reverse Cholesterol Transport From Peripheral Tissue Macrophages
Sehayek, E., & Hazen, S. L. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.165803 · Cited by 64
Rationale of the diet-heart statement of the American Heart Association. Report of the Nutrition Committee.
Chait, A., Brunzell, J. D., Denke, M. A., Eisenberg, D., Ernst, N. D., Franklin, F. A., Ginsberg, H., Kotchen, T. A., Kuller, L. H., & Mullis, R. M. (1993) · Circulation · doi:10.1161/01.cir.88.6.3008 · Cited by 256
Interrelationship of Free Oxygen Radicals and Endothelial Dysfunction--Modulation by Statins
Waßmann, S., & Nickenig, G. (2003) · Endothelium · doi:10.1080/10623320303357 · Cited by 64
Epidemiology of low cholesterol levels in older adults. The Cardiovascular Health Study.
Manolio, T. A., Ettinger, W. H., Tracy, R. P., Kuller, L. H., Borhani, N. O., Lynch, J. C., & Fried, L. P. (1993) · Circulation · doi:10.1161/01.cir.87.3.728 · Cited by 64
Cholesterol lowering as a treatment for established coronary heart disease.
LaRosa, J. C., & Cleeman, J. I. (1992) · Circulation · doi:10.1161/01.cir.85.3.1229 · Cited by 65
Nonstatin Low-Density Lipoprotein–Lowering Therapy and Cardiovascular Risk Reduction—Statement From ATVB Council
Hegele, R. A., Gidding, S. S., Ginsberg, H. N., McPherson, R., Raal, F. J., Rader, D. J., Robinson, J. G., & Welty, F. K. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.306442 · Cited by 63
Reductions in cardiovascular risk after bariatric surgery
Benraouane, F., & Litwin, S. E. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32834b7fc4 · Cited by 64
Topology Scanning and Putative Three-Dimensional Structure of the Extracellular Binding Domains of the Apical Sodium-Dependent Bile Acid Transporter (SLC10A2)
Zhang, E. Y., Phelps, M. A., Banerjee, A., Khantwal, C. M., Chang, C. K., Helsper, F., & Swaan, P. W. (2004) · Biochemistry · doi:10.1021/bi049270a · Cited by 63
Secondary prevention with fluvastatin decreases levels of adhesion molecules, neopterin and C-reactive protein
van Haelst, P. L., van Doormaal, J. J., May, J. F., Gans, R. O. B., Crijns, H. J. G. M., & Tervaert, J. W. C. (2001) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(01)00172-8 · Cited by 63
Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia
Cheung, M. C., Austin, M. A., Moulin, P., Wolf, A. C., Cryer, D., & Knopp, R. H. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90089-d · Cited by 63
Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol.
Stewart, B. F., Brown, B., Zhao, X., Hillger, L., Sniderman, A., Dowdy, A., Fisher, L. D., & Albers, J. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90635-1 · Cited by 65
Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk
Weingärtner, O., Lütjohann, D., Böhm, M., & Laufs, U. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.01.003 · Cited by 61
Effect Of Plasma Cholesterol On Red Blood Cell Oxygen Transport
Buchwald, H., O’Dea, T. J., Menchaca, H. J., Michalek, V. N., & Rohde, T. D. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03383.x · Cited by 61
Self-citation
Beyond cholesterol: the enigma of atherosclerosis revisited
Lackner, K. J., Han, S., Torzewski, M., Husmann, M., & Bhakdi, S. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-12-0733 · Cited by 61
Cholesterol and total mortality: need for larger trials.
Collins, R., KEECH, A. C., Peto, R., Sleight, P., KJEKSHUS, J. K., Wilhelmsen, L., MacMahon, S. W., Shaw, J., Simes, J., & D, E. B. M. (1992) · BMJ · doi:10.1136/bmj.304.6843.1689 · Cited by 61
The Cost of Reaching National Cholesterol Education Program (NCEP) Goals in Hypercholesterolaemic Patients
Koren, M. J., Smith, D. G., Hunninghake, D. B., Davidson, M. H., McKenney, J. M., Weiss, S. R., Schrott, H. G., Henley, R. W., Tresh, P., McLain, R. W., et al. (1998) · PharmacoEconomics · doi:10.2165/00019053-199814010-00006 · Cited by 59
Cholesterol reduction and its impact on coronary artery disease and total mortality
Holme, I. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80465-2 · Cited by 57
Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: use of meta-analysis
Holme, I. (1993) · Heart · doi:10.1136/hrt.69.1_suppl.s42 · Cited by 59
Serial volumetric intravascular ultrasound assessment of arterial remodeling in left main coronary artery disease.
Shiran, A., Mintz, G., Leiboff, B., Kent, K., Pichard, A., Satler, L., Kimura, T., Nobuyoshi, M., & Leon, M. (1999) · American Journal of Cardiology · doi:10.1016/s0002-9149(99)00119-8 · Cited by 50
One Year Improvements in Cardiovascular Risk Factors: a Comparative Trial of Laparoscopic Roux-en-Y Gastric Bypass vs. Adjustable Gastric Banding
Woodard, G. A., Peraza, J., Bravo, S., Toplosky, L., Hernandez‐Boussard, T., & Morton, J. M. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0088-0 · Cited by 57
Statin‐Associated Pleiotropy: Possible Beneficial Effects Beyond Cholesterol Reduction
Ito, M. K., Talbert, R. L., & Tsimikas, S. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.7part2.85s · Cited by 59
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
Sever, P. S., Dahlöf, B., & Poulter, N. R. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00278-2 · Cited by 58
The Role of AP-1 in the Transcriptional Regulation of the Rat Apical Sodium-dependent Bile Acid Transporter
Chen, F., Ma, L., Al‐Ansari, N., & Shneider, B. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104511200 · Cited by 58
Hypercholesterolaemia – practical information for non-specialists
Soran, H., Adam, S., Mohamad, J. B., Ho, J. H., Schofield, J. D., Kwok, S., Siahmansur, T. J., Liu, Y., Syed, A. A., Dhage, S. S., et al. (2018) · Archives of Medical Science · doi:10.5114/aoms.2018.72238 · Cited by 59
Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology
Ray, K. K., & Cannon, C. P. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200412000-00003 · Cited by 57
Retardation and arrest of progression or regression of coronary artery disease: A review
Vos, J., de Feyter, P. J., Simoons, M. L., Tijssen, J. G. P., & Deckers, J. W. (1993) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(93)90028-c · Cited by 57
Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part IV: The 1984 Coronary Primary Prevention Trial ends it—almost
Steinberg, D. H. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r500014-jlr200 · Cited by 56
Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation
Evans, M., Rumberger, J. A., Azumano, I., Napolitano, J. J., Citrolo, D., & Kamiya, T. (2014) · Vascular Health and Risk Management · doi:10.2147/vhrm.s57116 · Cited by 56
Impact of cholesterol reduction on peripheral arterial disease in the Program on the Surgical Control of the Hyperlipidemias (POSCH)
Buchwald, H., Bourdages, H. R., Campos, C. T., Nguyen, P. A. H., Williams, S. E., & Boen, J. R. (1996) · Surgery · doi:10.1016/s0039-6060(96)80016-x · Cited by 56
Self-citation
Bilirubin cycles enterohepatically after ileal resection in the rat
Brink, M., Méndez‐Sánchez, N., & Carey, M. C. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964422 · Cited by 55
Effects of Modifying Triglycerides and Triglyceride-rich Lipoproteins on Cardiovascular Outcomes
Abdel-Maksoud, M. F., Sazonov, V., Gutkin, S. W., & Hokanson, J. E. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318165e2e7 · Cited by 54
The Success Story of LDL Cholesterol Lowering
Pedersen, T. R. (2016) · Circulation Research · doi:10.1161/circresaha.115.306297 · Cited by 56
Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)
Bays, H. E., Kothari, S. N., Azagury, D. E., Morton, J. M., Nguyen, N. T., Jones, P. H., Jacobson, T. A., Cohen, D. E., Orringer, C. E., Westman, E. C., et al. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.01.007 · Cited by 55
Effects of 2164U90 on ileal bile acid absorption and serum cholesterol in rats and mice.
Lewis, M. C., Brieaddy, L. E., & Root, C. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39868-0 · Cited by 54
Antihypertensive therapy: Taking lipids into consideration
Grimm, R. H. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90811-u · Cited by 54
Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias
Glueck, C. J., Oakes, N., Speirs, J., Tracy, T., & Lang, J. E. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91380-m · Cited by 54
State-of-the-art update and review: clinical trials of lipid-lowering agents
Kwiterovich, P. O. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00957-6 · Cited by 54
The role of statins in clinical medicine -LDL - cholesterol lowering and beyond
Rutishauser, J. (2006) · Swiss Medical Weekly · doi:10.4414/smw.2006.11170 · Cited by 53
Diminished gene expression of ileal apical sodium bile acid transporter explains impaired absorption of bile acid in patients with hypertriglyceridemia
Duane, W. C., Hartich, L. A., Bartman, A. E., & Ho, S. B. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33450-7 · Cited by 53
Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy
McGladdery, S. H., & Frohlich, J. J. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31517-0 · Cited by 52
Indications for low-density lipoprotein apheresis.
Gordon, B. R., Stein, E. A., Jones, P. H., & Illingworth, D. (1994) · American Journal of Cardiology · doi:10.1016/0002-9149(94)90461-8 · Cited by 49
Dyslipidemia Profiles in Patients with Peripheral Artery Disease
Aday, A. W., & Everett, B. M. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1129-5 · Cited by 51
A brief review paper of the efficacy and safety of atorvastatin in early clinical trials.
Bakker-Arkema, R., Best, J. D., Fayyad, R., Heinonen, T., Marais, A., Nawrocki, J., & Black, D. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06066-8 · Cited by 45
Nitric Oxide Mediates the Effect of Fluvastatin on Intercellular Adhesion Molecule-1 and Platelet Endothelial Cell Adhesion Molecule-1 Expression on Human Endothelial Cells
Xenos, E. S., Stevens, S. L., Freeman, M. B., Cassada, D. C., & Goldman, M. H. (2005) · Annals of Vascular Surgery · doi:10.1007/s10016-005-0011-7 · Cited by 51
Marked benefit with sustained-release niacin therapy in patients with “isolated” very low levels of high-density lipoprotein cholesterol and coronary artery disease
Lavie, C. J., Mailander, L., & Milani, R. V. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90868-y · Cited by 51
Extent and distribution of coronary artery disease: A comparative study of invasive versus noninvasive angiography with computed angiography
Butler, J., Shapiro, M. D., Reiber, J. H. C., Sheth, T., Ferencik, M., Kurtz, E. G., Nichols, J. H., Pena, A. J., Cury, R. C., Brady, T. J., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2006.11.022 · Cited by 50
Task force 4. Efficacy of risk factor management
Forrester, J. S., Merz, C. N. B., Bush, T. L., Cohn, J. N., Hunninghake, D. B., Parthasarathy, S., & Superko, H. R. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)87732-1 · Cited by 50
Characterization and chemical modification of the Na+-dependent bile-acid transport system in brush-border membrane vesicles from rabbit ileum
Kramer, W., Nicol, S., Girbig, F., Gutjahr, U., Kowalewski, S., & Fasold, H. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90278-t · Cited by 50
KIF6 Polymorphism as a Predictor of Risk of Coronary Events and of Clinical Event Reduction by Statin Therapy
Li, Y., Iakoubova, O. A., Shiffman, D., Devlin, J. J., Forrester, J. S., & Superko, H. R. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.05.033 · Cited by 51
Tracking atherosclerosis regression: a clinical tool in preventive cardiology
Taylor, A. J., Shaw, L. J., Fayad, Z. A., O’Leary, D., Brown, B. G., Nissen, S. E., Rader, D. J., & Raggi, P. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.024 · Cited by 49
Reporting Risks and Benefits of Therapy by Use of the Concepts of Unqualified Success and Unmitigated Failure
Mancini, G. B. J., & Schulzer, M. (1999) · Circulation · doi:10.1161/01.cir.99.3.377 · Cited by 47
The Secondary Prevention of Coronary Artery Disease
Merz, C. N. B., Rozanski, A., & Forrester, J. S. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00046-6 · Cited by 47
Cholesterol, Primary and Secondary Prevention, and All-Cause Mortality
Criqui, M. H. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-12-973 · Cited by 45
Mechanism of Hypocholesterolemic Action of S-8921 in Rats: S-8921 Inhibits Ileal Bile Acid Absorption
Ichihashi, T., Izawa, M., Miyata, K., Mizui, T., Hirano, K., & Takagishi, Y. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37197-6 · Cited by 45
Recent advances in metabolic and bariatric surgery
Albaugh, V. L., Flynn, C. R., Tamboli, R. A., & Abumrad, N. N. (2016) · F1000Research · doi:10.12688/f1000research.7240.1 · Cited by 44
Increased activity of hepatic microsomal triglyceride transfer protein and bile acid synthesis in gallstone disease†
Castro, J., Amigo, L., Miquel, J. F., Gälman, C., Crovari, F. J., Raddatz, A., Zanlungo, S., Jalil, R., Rudling, M. J., & Nervi, F. O. (2007) · Hepatology · doi:10.1002/hep.21616 · Cited by 44
Efeito da berinjela sobre os lípides plasmáticos, a peroxidação lipídica e a reversão da disfunção endotelial na hipercolesterolemia experimental
Jorge, P. A. R., Neyra, L. C., Osaki, M. R., de Almeida, E., & Bragagnolo, N. (1998) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x1998000200004 · Cited by 44
The farnesoid X receptor: a novel drug target?
Claudel, T., Sturm, E., Kuipers, F., & Staels, B. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.9.1135 · Cited by 44
Cerivastatin prevents tumor necrosis factor-α-induced downregulation of endothelial nitric oxide synthase: role of endothelial cytosolic proteins
González-Fernández, F., Jiménez, A., López-Blaya, A., Velasco, S., Arriero, M., Celdrán, Á., Rico, L., Farré, J., Casado, S., & López-Farré, A. J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00535-9 · Cited by 44
Reversal of coronary atherosclerosis. Clinical promise as the basis for noninvasive management of coronary artery disease.
Gould, K. L. (1994) · Circulation · doi:10.1161/01.cir.90.3.1558 · Cited by 44
Iron versus cholesterol—Perspectives on the iron and heart disease debate
Sullivan, J. L. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00269-7 · Cited by 44
Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events
Brown, B. G., Zhao, X.-Q., Sacco, D., & Albers, J. J. (1993) · Heart · doi:10.1136/hrt.69.1_suppl.s48 · Cited by 44
Atherosclerosis: Making a U Turn
Goldberg, I. J., Sharma, G. K., & Fisher, E. A. A. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-042418-011108 · Cited by 44
HMG-CoA reductase inhibitors
Illingworth, D. R., & Tobert, J. A. (2001) · Advances in protein chemistry · doi:10.1016/s0065-3233(01)56003-9 · Cited by 43
Development of new coronary atherosclerotic lesions during a 4-year multifactor risk reduction program: The stanford coronary risk intervention project (SCRIP)
Quinn, T. G., Alderman, E. L., McMillan, A., & Haskell, W. L. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90848-6 · Cited by 43
Effects of Long-Term Treatment with Taurine in Mice Fed a High -Fat Diet
Murakami, S., Kondo, Y., & Nagate, T. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46838-7_19 · Cited by 42
Serum Cholesterol, Lifestyle, Working Capacity and Quality of Life in Patients with Coronary Artery Disease. Experiences from a Hospital-based Secondary Prevention Programme
Carlsson, R. (1998) · Scandinavian Cardiovascular Journal · doi:10.1080/140174398427956-1 · Cited by 42

Authors: Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., Sawin, H. S., Campos, C. T., Hansen, B. J., Tuna, N., Karnegis, J. N., Sanmarco, M. E., Amplatz, K., Castaneda-Zuniga, W. R., Hunter, D. W., Bissett, J. K., Weber, F. J., Stevenson, J. W., Leon, A. S., & Chalmers, T. C.
Affiliations: University of Minnesota (US)
University of Southern California (US)
ORCID: Long, John M.
Hunter, David W.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1990-10-04
Volume: 323
Issue: 14
Pages: 946-955
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199010043231404
OpenAlex: W2331959986
Cited by: 1,001
References: 58
Citations by year: 2026: 3 · 2025: 2 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 20 · 2020: 11 · 2019: 16 · 2018: 10 · 2017: 11 · 2016: 22 · 2015: 15 · 2014: 17 · 2013: 12 · 2012: 17
FWCI: 84.71
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: partial ileal bypass, hypercholesterolemia, coronary artery disease, mortality, myocardial infarction, cholesterol lowering, LDL cholesterol, HDL cholesterol, first myocardial infarction, coronary artery bypass grafting, ejection fraction, long-term outcomes, nonfatal myocardial infarction
MeSH terms: Adult, Coronary Disease, Electrocardiography, Female, Follow-Up Studies, Humans, Hypercholesterolemia, Hyperlipidemias, Jejunoileal Bypass, Lipids, Male, Middle Aged, Ultrasonography, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Coronary Angiography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks